Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers

Cancer

Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers

The vaccine could be available as soon as 2027.

Ronald Bailey | 8.19.2026 3:40 PM

Share on FacebookShare on XShare on RedditShare by emailPrint friendly versionCopy page URL Add Reason to Google

Media Contact & Reprint Requests

(Guteksk7/Dreamstime.com/National Institutes of Health)

Pharmaceutical companies Moderna and Merck announced today the highly promising results of their anti-cancer mRNA vaccine Phase 3 clinical trial targeting later-stage melanoma skin cancers.

Researchers sequenced the DNA from each patient's tumors to create personalized vaccines that, when injected, rev up the immune system to........

© Reason.com